Israel Englander Biora Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.13 - $12.03 $120,145 - $11.1 Million	924,199 Added 99.33%	1,854,620 $244,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $177,563 - $4.46 Million	-335,025 Reduced 26.47%	930,421 $451,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $429,169 - $934,976	-766,374 Reduced 37.72%	1,265,446 $886,000
Q1 2022 May 16, 2022	BUY	$1.11 - $2.25 $1.75 Million - $3.56 Million	1,580,264 Added 349.96%	2,031,820 $2.36 Million
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $570,674 - $2.07 Million	422,722 Added 1466.05%	451,556 $944,000
Q3 2021 Nov 15, 2021	SELL	$0.67 - $3.41 $65,287 - $332,284	-97,444 Reduced 77.17%	28,834 $44,000
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $161,254 - $376,770	76,424 Added 153.3%	126,278 $451,000
Q1 2021 May 17, 2021	SELL	$3.91 - $7.31 $129,800 - $242,670	-33,197 Reduced 39.97%	49,854 $237,000
Q4 2020 Feb 16, 2021	SELL	$3.27 - $9.48 $115,941 - $336,122	-35,456 Reduced 29.92%	83,051 $441,000
Q3 2020 Nov 16, 2020	BUY	$7.71 - $10.79 $2,675 - $3,744	347 Added 0.29%	118,507 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$9.0 - $13.12 $1.06 Million - $1.55 Million	118,160 New	118,160 $1.06 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.